Increment_Utilization_Accomplishment_Report_Blank_Book_RevB(March_2019).docx

RPWG-02-Inc XX/YY Date (month & year) Basic RPWG-02-Inc XX/YY

Increments XX & YY Utilization Accomplishment Report Blank Book

International Space Station Program

Date (month & year)

National Aeronautics and Space Administration International Space Station Program Johnson Space Center Houston, Texas

REVISION AND HISTORY PAGE

International Space Station Program Increments XX & yy UTILIZATION accomplishment report BLANK BOOK

PREFACE

This document provides a summary of the utilization activities and accomplishments that occurred during Increments XX & YY. This document is developed by the International Space Station Program Increment Research Team (IRT) community under direction of the Multilateral Research Planning Working Group (MRPWG).

· Instructions are provided in red font and are to be removed prior to publishing the final increment specific UAR.

· Data fields that require updating and/or need to be confirmed when building the Increment specific UAR template are shown in blue font in the blank book. The text should be changed to black font once it is updated. Examples of tables and figures are provided in the blank book.

· Reference the IRT Process, IRT-POST.04 Utilization Accomplishment Report, for milestones.

INTERNATIONAL SPACE STATION PROGRAM

increments XX & YY UTilization accomplishment report

CONCURRENCE

Date (month, year)

Prepared by:

MAPI/OP

Book Manager (RIE Lead)

ORG

Signature

DATE

Concurred by:

NASA

RPWG Chair

ORG

Signature

DATE

CSA

ORG

Signature

DATE

ESA

ORG

Signature

DATE

JAXA

ORG

Signature

DATE

INTERNATIONAL SPACE STATION PROGRAM

increments XX & YY UTilization accomplishment report list of changes Date (month & year)

All changes to paragraphs, tables, and figures in this document are shown below:

TABLE OF CONTENTS

Contents

1.0 Introduction

This report is a summary of the research utilization requirements, activities and accomplishments completed during Increments XX & YY. Excerpts from this report will be used in the development of the Consolidated Operations and Utilization Plan (COUP) Annual Report and SSP 543XX-543YY, Post Increment Evaluation Report (PIER).

1.1 Purpose

The primary purpose of this document is to record the utilization activities and accomplishments of Increments XX & YY. The secondary focus of this report is to compare “as-flown” performance against the pre-increment baselined plan and to explain discrepancies and deviations. Excerpts from this report will be used in the development of the Consolidated Operations and Utilization Plan (COUP) Annual Report and SSP 543XX-543YY, Post Increment Evaluation Report (PIER).

2.0 Reference Documents and Data Libraries

The following documents and data sources contain supplemental information to provide additional context to the information included in this document. These reference documents may or may not be specifically cited within the text of this document.

https://iss.sp.jsc.nasa.gov/Int/OZ/OZ5/IncrementResearchTeam/SitePages/Home.aspx

https://iss.sp.jsc.nasa.gov/Int/OZ/OZ5/SitePages/RPWG.aspx

https://iss-science.jsc.nasa.gov/

3.0 Increment Overview

The LIS and RIE Lead will include a summary of USOS Utilization during the increment pair – i.e. impacts of vehicle traffic, JEMAL science, etc. (example below). Note: Partner specific science accomplishments and challenges will be addressed in Sections 5 and 6 of the UAR.

The intent is to provide the Utilization summary to the Increment Management Team (IMT) to be included in the increment overview used in the PIER document (developed by the IMT and identifies the expedition crewmembers, transportation vehicles and their flight sequence, and any major milestones of particular interest or uniqueness). The PIER overview summary includes a summary of the major ISS events impacting the increment.

The final Increment Overview summary in the UAR will include the same overview language used in the PIER document. The source of the data will be sited.

Utilization Summary input Example:

The Increments 55 and 56 Research Plan included 357 investigations with 123 investigators represented. Although we were not able to meet the increased USOS utilization allocation, Increment 55/56 did set a record for the number of hours of USOS utilization completed in an Increment pair at 1711 hours. Close to one third of the increment weeks, reflected 68.5 hours or more dedicated to Utilization.

SpX-14 brought over thirty experiments and/or facilities to ISS. Several crossover investigations arrived, operated, and returned with SpX-14 including APEX-06, CASIS PCG 9, Fruit Fly Lab-03, Genes in Space-5, Invitrobone, Made in Space Fiber Optics-2, Metabolic Tracking, Mouse Stress Defense, MVP Fly-01, NanoRacks Module-66, and Payload Card-6. In addition, SpX-14 returned other Utilization hardware including Robonaut, which returned for repair.

A variety of new USOS Utilization arrived on OA-9 including NASA’s new facility, Cold Atom Lab (CAL), and ESA’s International Commercial Experiment Cubes (ICE Cubes) Facility.

· CAL is a facility that produces clouds of atoms that are chilled to about one ten billionth of a degree above absolute zero -- much colder than the average temperature of deep space. At these low temperatures, atoms have almost no motion, allowing scientists to study fundamental behaviors and quantum characteristics that are difficult or impossible to probe at higher temperatures. In microgravity, researchers may be able to achieve even colder temperatures than what is possible on the ground, and observe these cold atom clouds for longer periods of time.

· The objective of the ICE Cubes Facility (ICF) is to provide rapid, simplified, low-cost access service to the ISS, increasing the exploitation opportunity of the ISS for the remaining lifetime and widening its access to new organizations/entities on a commercial basis.

Over forty experiments launched on SpX-15. During the SpX-15 mission, the crew spent a significant amount of time performing the Rodent Research-7 (RR-7) (including planned augmented crew days for the first time) and Angiex Cancer Therapy investigations. JAXA’s Amyloid experiment also arrived and returned on SpX-15.

· Angiex Cancer Therapy examined whether endothelial cells, cultured in microgravity represent a valid in vitro model to test effects of vascular-targeted agents on normal blood vessels. Angiex has developed a treatment that targets both tumor cells and vasculature, but needs a better model on which to test it. The study may facilitate a cost-effective method that does not require animal testing and which may help develop safer and more effective vascular-targeted drugs.

· RR-7 investigation examined how the space environment affects the community of microorganisms in the gastrointestinal tract of mice (also known as the microbiota). It also looks at microgravity’s effects on multiple physiological systems known to be affected by the microbiota, including the gastrointestinal, immune, metabolic, circadian, and sleep systems.

· Amyloid fibrils are protein aggregations associated with Alzheimer’s disease and diabetes. Developing new treatments requires understanding the mechanisms behind amyloid fibril formation. Recent evidence suggests similarities between amyloid formation and protein crystallization, widely studied in space. Characterization of Amyloid Formation Under Microgravity Environment: Toward Understanding the Mechanisms of Neurodegenerative Diseases (Amyloid) prepared high-quality, homogeneous amyloid fibrils in microgravity and will examine the samples back on Earth, using nuclear magnetic resonance (NMR) and electron microscopic analyses, to characterize the fibrilization process.

JEM AL Utilization operations in Increments 55 and 56 included nine experiments:

· MISSE-FF MSC exchange occurred in March 2018.

· J-SSOD#8 arrived on SpX-14 and deployed in May 2018.

· ExHAM#2 arrived on SpX-14 and exchanged in May 2018.

· NanoRacks-Remove Debris arrived on SpX-14 and deployed in June 2018 (first use of the Slide Table AM for KABER).

· NRCSD #14 arrived on OA-9 and deployed in July 2018.

· ExHAM#1 exchange occurred in July 2018.

· J-SSOD#9 arrived on SpX-15 and deployed in August 2018.

· DESIS arrived on SpX-15 and installed onto the MUSES platform in August 2018.

· HDTV-EF2 arrived on SpX-15; Camera R&R occurred in September 2018.

Figure 3.0-1 ISS Increments XX & YY Overview Final IMT Increment Overview Chart

[Final IMT Increment Overview Chart from OC SharePoint]

4.0 Research Summary

The International Space Station Program mission is to advance science and technology research, expand human knowledge, inspire and educate the next generation, foster the commercial development of space and demonstrate capabilities to enable future exploration missions beyond low Earth orbit. The research objectives of Increments XX & YY supported this mission via experiments in biology and biotechnology, earth and space sciences, educational and cultural activities, human research, physical and materials sciences and technology development (reference Appendix C).

Figure 4.0-1 graphically shows the percentage distribution of research in the various categories.

Figure 4.0-1 Investigations by Category

[Generated by the RIE Lead, includes all investigations in the Research Plan]

Figure 4.0-2 shows the “As Planned” investigation list by category. This list includes all investigations and facilities included in the Increments XX & YY Research Plan.

Figure 4.0-2 Investigations by Category

[Developed by the RIE Lead during the pre-increment timeframe and maintained throughout the increment pair. The categories in this list should match the Program Scientist Office and CSA, ESA, and JAXA categories.]

5.0 USOS Utilization Operations Summary and Research Statistics

· The intent is for Section 5 (all) to be used to develop the COUP Annual Report.

· The LIS and RIE Lead will insert a narrative of one or more paragraphs to describe the overall summary of the USOS Utilization operations during the increment pair, including how the major increment events listed in Section 3 impacted/improved the USOS utilization allocation during the increment, resulting in the crewtime totals shown in the crewtime summary figure.

Figure 5.0-1 shows the actual crew time usage per week plotted against the working version of the On-Orbit Operations Summary planned requirements, given additions and deletions in real-time increments.

FIGURE 5.0-1 Utilization Crew Time Usage Final red bar/blue bar chart, developed by the Crew Time Engineer (CTE)

Table 5.0-1 lists all USOS investigations that were active during Increments XX and YY. Note that while a single name for an investigation may be listed, this may cover several investigations.

Table 5.0-1 Increments XX/YY Investigation List “As Executed” investigation list developed by the Strategic Planning/UOP Group

Increments 55/56 Investigation List Biology & Biotechnology

Educational Activities

Technology Development and Demonstration

Human Research

GENE CONTROL PRIME

EPO GERST EARTH GUARDIAN SEEDS

MVIS

At Home in Space

IN VITRO BONE

EPO GERST FLYING CLASSROOM

RaDI-N-2

Marrow

Cell Free Epigenome

EPO GERST GENERIC VIDEOS

FLUIDICS

TBone

JAXA PCG

ESA ASTRO-PI 2.0

MAGVECTOR

Vascular Echo

Low Temp PCG

Candida albicans Growth Inhibition

MARCONISSTA

Wayfinding

Moderate Temp PCG

EnduroSat One

METABOLIC SPACE

AIRWAY MONITORING

Multi-Omics-Mouse

EQUiSat

MATISS-2

BRAIN-DTI

Saibo LM1

Future Engineers - Two for the Crew

METERON SUPVIS-JUSTIN

CIRCADIAN RHYTHM

Space Pup

Genes in Space-5

MOBI-PV

CULT

Angiex Cancer Therapy

ISS Ham Radio - CASIS

SPACETEX-2

GRASP

APEX-06

ISSET-3

WIRELESS COMPOSE

GRIP

Arabidopsis thaliana

Megachile rotundata Proprioception and Flight Patterns in Microgravity

WISENET

MYOTONES

BEST

NanoRacks-DreamUp Xtronaut Crystal Growth (DreamXCG

VESSEL ID SYSTEM

SPACE HEADACHES

Biological Nitrogen Fixation

NanoRacks-NCESSE-Mercury

Area PADLES

STRAIGHT AHEAD IN MICROGRAVITY

CASIS PCG 6/11

NanoRacks-RSL-02

ExHAM:ARM

TIME

CASIS PCG 8

One Strange Rock Virtual Reality

ExHAM:CFRP Mirror

IPVI

CASIS PCG 9

PRISMSpace-1

ExHAM: Film Dosimeter

Labyrinth

CASIS PCG 13

Quest Institute Lab-1

ExHAM: LCR

Medical Proteomics

Fruit Fly Lab-03

Sally Ride EarthKAM - NLO

ExHAM: Microwave Amplifier

Multi Omics

Germination of ABI Voyager Barley Seeds in Microgravity

Space Tango-CCS-Magnetic Qualities of Magnetorheological Fluids

ExHAM: PEEK

Probiotics

Growth of Assorted Microgreens in Microgravity

Space Tango-CKS-3D Maze Slime Mold

ExHAM: Radiation Shielding

Biochem Profile

LMM Biophysics 4

Space Tango-MA-Copper Crystallization in Microgravity

ExHAM:Tanpopo

Field Test

Metabolic Tracking

Space Tango-SAS-Electroplating

JEM Internal Ball Camera

Fluid Shifts

Micro-11

Space Tango-SDYSP-Decomposition

J-SSOD #8

Micro-12

Space Tango-SUTHC-Magnetorheological Fluids

J-SSOD #9

Food Acceptability

MVP Fly-01

Space Tango-VCHS Dublin-Slime Mold Growth

Nano-Bubble Demo

Functional Immune

NanoRacks-NDC-CCSJ-Beta-Amyloid Peptide

Space Tango-VCHS Dublin- Copper Paint

PS-TEPC

Lighting Effects

Plant Gravity Perception

Space Tango-VCHS Dublin- Ferrofluid-Geiger Counter-Light Propulsion

Active Tissue EquivalentDosimeter

Medical Consumables Tracking

Plant Habitat-01

Space Tango-VCHS Dublin- Lactococcus Fermentation

AeroCube 12 A&B

Neuromapping

Rodent Research-7 (RR-7)

Space Tango-VCHS Dublin-Microbial Fuel Cell

Aerosol Samplers

One-Carbon Expansion

Smooth Muscle Cells-2

Space Tango-VCHS Dublin-Plant Growth in Microgravity

AMF-ABS Design Values

Repository

Space Algae

Space Tango-VCHS Dublin-Sharklet

BEAM

Soyuz Occupant Risk

STaARS BioScience-8-Gene Control-Prime-EPICON

SPHERES-Zero-Robotics

BPC-1

Team Task Switching

STaARS BioScience-8-Gene Control Prime-FARAGIS

Story Time

CaNOP

STaARS BioScience-9

Windows on Earth

DUST

CSA

Veg-03

FLUMIAS-DEA

ESA

Veggie PONDS Validation

Earth & Space Science

FNS

JAXA

DOSIS-3D

HDEV

NASA

Physical Science

CALET

Made in Space - Granular Damping Specimens

ASIM

MAXI

Made in Space Fiber Optics

EML Batch1/COOLCOP

SEDA-AP

Made in Space Fiber Optics 2

EML Batch1/MAGNEPHAS

AMS-02

MED-2

EML Batch1/METCOMP

ARISE

MemSat

EML Batch1/MULTIPHAS

CEO

MICS

EML Batch1/NEQUISOL

CubeRRT

Miniaturized Particle Telescope

EML Batch1/PARSEC

DESIS

MISSE-9-NASA

EML Batch1/THERMOLAB

Earth Imagery from ISS

Moon Imagery

EML Batch1/THERMOPROP

ECOSTRESS

NanoRacks-LEMUR-2

EML Batch2/CCEMLCC

HaloSat

NanoRacks-Remove Debris

EML Batch2/COOLCOP

ISS-CREAM

PAPELL

EML Batch2/ICOPROSOL

Meteor

Radiation Environment Monitoring

EML Batch2/MAGNEPHAS

NICER

Radix

EML Batch2/NEQUISOL

SAGE III-ISS

RadSat-g

EML Batch2/PARSEC

STP-H5 FPS

RainCube

EML Batch2/RESISTIVITY

STP-H5 LIS

RFID Logistics Awareness

EML Batch2/SEMITHERM

TEMPEST-D

SCAN Testbed

EML Batch2/THERMOLAB

Total & Spectral solar Irradiance Sensor (TSIS)

Sextant Navigation

EML Batch2/THERMOPROP

TROPICAL CYCLONE

SG100 Cloud Computer

PK4

SmoothNav

SOFT MATTER DYNAMICS/COMPACTED GRANULARS

Space Tango Fan

TRANSPARENT ALLOYS/ / SEBA

Space Tango Thermal Evaluation Module

Amyloids

Spaceborne Computer

Atomization

SPHERES Tether Slosh

ELF

SPHERES-ReSwarm

ELF: Interfacial Energy (IE)

STP-H5 CSP

Spirits Maturation (Commercial)

STP-H5 EHD

Two Phase Flow

STP-H5 GROUP-C

ACE-M-2

STP-H5 ICE

ACE-T-2

STP-H5 iMESA-R

ACE-T-6

STP-H5 LITES

ACE-T-7

STP-H5 Raven

ACE-T-9

STP-H5 RHEME

Barrios PCG

STP-H5 SHM

BCAT-CS

STP-H5 Space Cube-Mini

Chemical Gardens

STP-H5-APS

CLD Flame

Telescience Resource Kit

Continuous Liquid-Liquid Separation in Microgravity

Universal Waste Management System (UWMS)

DECLIC-ALI-R

WetLab-2 Parra

DECLIC-DSI-R

Zero-g Battery Testing

E-FIELD Flames

QUANTUM

Surface Tension Containment Experiment-2

Figure 5.0-2 illustrates the numbers of new, on-going, and complete investigations for Increments XX & YY, shown by Partner. It must be noted that many investigations are planned to continue from increment to increment as long-term studies and some investigations are rolled over to future increments when they cannot be executed as planned.

Figure 5.0-2 Increment XX/YY Investigations Developed by the Strategic Planning/UOP Group

Sections 5.1-5.4 provide overviews of each partner’s utilization performance across the increment pair.

5.1 CSA

· Each partner should write a narrative describing the following aspects of their utilization operations in Increments XX and YY.

· Performance comparison against pre-increment plan (IDRD Rev. A and Final OOS). Include both qualitative statements about accomplishing the research planned and quantitative information about crewtime performance including use of MOU/CSOC allocation and any Voluntary Science, Task List or supplemental research accomplished.

· Key research successes, milestones or accomplishments for the agency this increment.

· Results of any commissioning activities performed

· How anomalies and rollovers affected completion of the agency’s objectives.

· Insert crewtime tracking matrix page after narrative

5.2 ESA

· Each partner should write a narrative describing the following aspects of their utilization operations in Increments XX and YY.

· Performance comparison against pre-increment plan (IDRD Rev. A and Final OOS). Include both qualitative statements about accomplishing the research planned and quantitative information about crewtime performance including use of MOU/CSOC allocation and any Voluntary Science, Task List or supplemental research accomplished.

· Key research successes, milestones or accomplishments for the agency this increment.

· Results of any commissioning activities performed

5.3 JAXA

· Each partner should write a narrative describing the following aspects of their utilization operations in Increments XX and YY.

· Performance comparison against pre-increment plan (IDRD Rev. A and Final OOS). Include both qualitative statements about accomplishing the research planned and quantitative information about crewtime performance including use of MOU/CSOC allocation and any Voluntary Science, Task List or supplemental research accomplished.

· Key research successes, milestones or accomplishments for the agency this increment.

· Results of any commissioning activities performed

5.4 NASA

· Each partner should write a narrative describing the following aspects of their utilization operations in Increments XX and YY.

· Performance comparison against pre-increment plan (IDRD Rev. A and Final OOS). Include both qualitative statements about accomplishing the research planned and quantitative information about crewtime performance including use of MOU/CSOC allocation and any Voluntary Science, Task List or supplemental research accomplished.

· Key research successes, milestones or accomplishments for the agency this increment.

· Results of any commissioning activities performed

· How anomalies and rollovers affected completion of the agency’s objectives.

· Insert crewtime tracking matrix page after narrative

6.0 Investigation Activities & Accomplishments

Details of the investigation accomplishments and research highlights conducted during Increments XX & YY are in Sections 6.1-6.4 separated by agency and research discipline within each agency. These summary tables include any preliminary scientific results from the investigations that are releasable at the time of this document publication and relevant operations details from performance of the investigations during the increment pair.

· Each partner should use the table format below for all research categories to provide a specific end-of-increment status for each investigation planned/conducted in the increment pair. Planned and completed columns should document the number of sessions. “Percentage of science completed” column is used to clarify whether completed sessions met all increment defined science objectives (this is important as “planned” equaling “completed” does not always mean 100% of the science was accomplished). Use the comments column to explain the data in the table. Information should include:

· Performance against pre-increment plan including rationale/explanation for under/over performance.

· How much of overall investigation objective was completed (for multi-increment investigations) and how much remains.

· Whether performance in current increment affects experiment planning for subsequent increments.

Agency / Category

Example:

Completed or Continuing or Roll-Over

- Highlight science observations.

- Include information regarding anomalies if applicable.

- Include significant achievements above and beyond requirements.

- Include overall experiment status (i.e. “Hypersole now has 3 of 9 required subjects”)

Status Definitions:

· Completed: all experiment requirements were completed by the end of the reporting period (i.e.: experiment is done and concluded)

· Continuing: the experiment will continue in subsequent increments (i.e. human research experiment will require additional subjects in subsequent increments).

· Rollover: increment requirements were not completed and will rollover to a future increment.

· % of Science Completed: the percentage of science completed versus the planned science for the increment (note: progress towards total science objectives should be included in the Comments section only).

6.1 CSA

CSA / Biology and Biotechnology

CSA / Earth and Space Science

CSA / Educational and Cultural Activities

CSA / Human Research

CSA / Physical Science

CSA / Technology Development and Demonstration

CSA / Facilities

6.2 ESA

XX/YY

ESA / Biology and Biotechnology

XX/YY

ESA / Earth and Space Science

ESA / Educational and Cultural Activities

ESA / Human Research

ESA / Physical Science

ESA / Technology Development and Demonstration

ESA / Facilities

6.3 JAXA

JAXA / Biology and Biotechnology

JAXA / Earth & Space Science

JAXA / Educational and Cultural Activities

JAXA / Human Research

JAXA / Physical Science

JAXA / Technology Development and Demonstration

JAXA / Facilities

6.4 NASA

NASA / Biology and Biotechnology

NASA / Earth and Space Science

NASA / Educational and Cultural Activities

NASA / Human Research

NASA / Physical Science

NASA / Technology Development and Demonstration

NASA / Facilities

7.0 Future Increment Carry Over

This section provides a summary of the Utilization activities not accomplished but recommended to be carried over for execution in the next or a future increment.

· 7.1 through 7.4 are placeholders for CSA, ESA, JAXA, and NASA roll-over activities. Using the table format below (example provided); include a list of roll-over activities and requirement descriptions. Include additional information as required in this section to explain the reasons for the roll-over. If an agency does not have roll-over activities, a brief statement should be included as such.

{Gathered from Roll-over CEF, SRTD, and/or hand-over presentation.]

Appendix A – Key Personnel List [Updated using the contact list and/or handover presentation] NASA Payload Operations

Mission Science Integrator (MSI) Focal > Mission Science Integrators Cindy Romero > Victor Vargas

Payload Operations Manager (POM) > Assistant Payload Operations Manager (APOM) Pat Patterson (I55), Derek Calvert (I56) > Joby Minor (I55), Katie Presson (I56)

ESA Payload Operations

Ruben Guimaraes (EPIC/CLIP)

JAXA Payload Operations

Increment Scientist > Increment Scientist Back-ups Haruo Kasahara > Yasuyuki Watabe

Increment Payload Manager (IPM), Prime > IPM Back-up Takefumi Sakaguchi > Kirokazu Yokoyama

CSA Payload Operations

Research Planning Leads

Appendix B - Acronyms and Abbreviations [The acronyms and abbreviations should be updated in the blank book as needed, so that the master list is always maintained in the blank book. The list may be updated in the increment specific document as applicable to that report.]

QCT Quantitative Computed Tomography

Appendix C – Research Objectives

[The tables below include experiments and research objectives (PAO summaries from the ISS Program Scientist Toolbox) that were expected to be accomplished in the increment pair.]

4.1 CSA Research

CSA

4.2 ESA Research

ESA

4.3 JAXA Research

JAXA

4.4 NASA Research

NASA

image1.jpeg image2.jpeg image3.jpeg image4.jpeg image5.emf image6.emf image7.emf image8.emf image9.emf image10.emf image11.emf image12.png image13.png